SCOPUS 정보 검색 플랫폼

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 11, 2001, Pages 1117-1120

Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment

(4) Gram, Inger T a Ursin, Giske b Spicer, Darcy V b Pike, Malcolm C b

a UNIVERSITY OF TROMSØ (Norway)

b UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; GONADORELIN AGONIST; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PREVENTION; CANCER SCREENING; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; OVARY FUNCTION; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; MAMMOGRAPHY; MEDROXYPROGESTERONE 17-ACETATE; PREMENOPAUSE;

EID: 0035173945 PISSN: 10559965 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (23)

References (19)

1
- 0027287944
- Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer
- (1993) Contraception , vol.47 , pp. 427-444
- Spicer, D.V.¹ Pike, M.C.² Pike, A.³ Rude, R.⁴ Shoupe, D.⁵ Richardson, J.⁶

2
- 0025991170
- GnRH agonists as contraceptive agents: Predicted significantly reduced risk of breast cancer
- (1991) Contraception , vol.44 , pp. 289-310
- Spicer, D.V.¹ Shoupe, D.² Pike, M.C.³

3
- 0028261782
- Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk
- (1994) J. Natl. Cancer Inst. , vol.86 , pp. 431-436
- Spicer, D.V.¹ Ursin, G.² Parisky, Y.R.³ Pearce, J.G.⁴ Shoupe, D.⁵ Pike, A.⁶ Pike, M.C.⁷

4
- 0023187963
- Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study
- (1987) Am. J. Roentgenol. , vol.148 , pp. 1087-1092
- Wolfe, J.N.¹ Saftlas, A.F.² Salane, M.³

5
- 0031951811
- The detection of changes in mammographic densities
- (1998) Cancer Epidemiol. Biomark. Prev. , vol.7 , pp. 43-47
- Ursin, G.¹ Astrahan, M.A.² Salane, M.³ Parisky, Y.R.⁴ Pearce, J.G.⁵ Daniels, J.R.⁶ Pike, M.C.⁷ Spicer, D.V.⁸

6
- 0006600341
- Duxbury, Pacific Grove, California
- (2000) Fundamentals of Biostatistics, Ed. 5 , pp. 338-343
- Rosner, B.¹

7
- 0035117970
- Mammographic density changes during the menstrual cycle
- (2001) Cancer Epidemiol. Biomark. Prev. , vol.10 , pp. 141-142
- Ursin, G.¹ Parisky, Y.R.² Pike, M.C.³ Spicer, D.V.⁴

8
- 0018746823
- Factors associated with breast structure in breast cancer patients
- (1979) Cancer (Phila.) , vol.43 , pp. 1895-1899
- Grove, J.S.¹ Goodman, M.J.² Gilbert, F.³ Clyde, D.⁴

9
- 0027213841
- Mammographic parenchymal patterns: A marker of breast cancer risk
- (1993) Epidemiol. Rev. , vol.15 , pp. 196-208
- Oza, A.M.¹ Boyd, N.F.²

10
- 0033574030
- Effects of estrogen and estrogen-progestin on mammographic parenchymal density
- Postmenopausal estrogerdprogestin interventions (PEPI) investigators
- (1999) Ann. Intern. Med. , vol.30 , pp. 262-269
- Greendale, G.A.¹ Reboussin, B.A.² Sie, A.³ Singh, H.R.⁴ Olson, L.K.⁵ Gatewood, O.⁶ Bassett, L.W.⁷ Wasilauskas, C.⁸ Bush, T.⁹ Barrett-Connor, E.¹⁰

11
- 0030722067
- Short-term cessation of hormone replacement therapy and improvement of mammographic specificity
- (1997) J. Natl. Cancer Inst. , vol.89 , pp. 1623-1625
- Harvey, J.A.¹ Pinkerton, J.V.² Herman, C.R.³

12
- 0028775002
- Hormonal reduction of mammographic densities: Potential effects on breast cancer risk and performance of diagnostic and screening mammography
- (1994) J. Natl. Cancer Inst. , vol.86 , pp. 408-409
- Feig, S.A.¹

13
- 0034700867
- Hormone replacement therapy and accuracy of mammography screening
- (2000) Lancet , vol.355 , pp. 270-274
- Kavanagh, A.M.¹ Mitchell, H.² Giles, G.G.³

14
- 0034608772
- Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers
- (2000) J. Natl. Cancer Inst. , vol.92 , pp. 1081-1087
- Mandelson, M.T.¹ Oestreicher, N.² Porter, P.L.³ White, D.⁴ Finder, C.A.⁵ Taplin, S.H.⁶ White, E.⁷

15
- 0023495331
- Mammographic parenchymal patterns and breast cancer risk
- (1987) Epidemiol. Rev. , vol.9 , pp. 146-174
- Saftlas, A.F.¹ Szklo, M.²

16
- 0028939039
- Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study
- (1995) J. Natl. Cancer Inst. , vol.87 , pp. 670-675
- Boyd, N.F.¹ Byng, J.W.² Jong, R.A.³ Fishell, E.K.⁴ Little, L.E.⁵ Miller, A.B.⁶ Lockwood, G.A.⁷ Tritchler, D.L.⁸ Yaffe, M.J.⁹

17
- 0028823773
- Mammographic features and breast cancer risk: Effects with time, age, and menopause status
- (1995) J. Natl. Cancer Inst. , vol.87 , pp. 1622-1629
- Byrne, C.¹ Schairer, C.² Wolfe, J.³ Parekh, N.⁴ Salane, M.⁵ Brinton, L.A.⁶ Hoover, R.⁷ Haile, R.⁸

18
- 0002526401
- Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen: Results from the ZIPP trial organised by the Cancer Research Campaign (CRC) Breast Cancer Trials Group
- (1999) Breast Cancer Res. Treat. , vol.57 , pp. 30
- Baum, M.¹

19
- 0034673201
- Effects of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
- (2000) J. Natl. Cancer Inst. , vol.92 , pp. 328-332
- Ross, R.K.¹ Paganini-Hill, A.² Wan, P.C.³ Pike, M.C.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.